loading

Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
37.25%
47.86
34.87 36.77 37.62 33.53
Operating Income/Loss
37.25%
-47.86
-34.87 -36.77 -37.62 -33.53
Nonoperating Income/Loss
9.01%
4.08
4.484 3.201 3.066 3.148
Income/Loss From Continuing Operations Before Tax
44.08%
-43.78
-30.39 -33.56 -34.55 -30.38
Income/Loss From Continuing Operations After Tax
44.08%
-43.78
-30.39 -33.57 -34.55 -30.38
Net Income/Loss
44.08%
-43.78
-30.39 -33.57 -34.55 -30.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.08%
85.50
85.43 5.5494 57.26 56.28
Diluted Average Shares
0.08%
85.50
85.43 5.5494 57.26 56.28
Basic Earnings Per Share
41.67%
-0.51
-0.36 -0.40 -0.60 -0.54
Diluted Earnings Per Share
41.67%
-0.51
-0.36 -0.40 -0.60 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$100.23
price down icon 4.64%
$33.63
price up icon 1.77%
$118.70
price down icon 0.13%
$116.03
price down icon 2.01%
$154.78
price down icon 3.22%
biotechnology ONC
$339.23
price up icon 0.08%
Capitalizzazione:     |  Volume (24 ore):